Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 13, No 6 (2017) THE ROLE OF CARVEDILOL IN THE PREVENTION OF CARDIOMYOCYTE APOPTOSIS CAUSED BY ACUTE MYOCARDIAL INFARCTION Abstract  similar documents
A. N. Zakirova, B. N. Garifullin, N. E. Zakirova
"... Data on the mechanisms of cardiomyocyte apoptosis in myocardial infarction are presented. It has ..."
 
Vol 6, No 5 (2010) INTERRELATION BETWEEN PERSISTENT NECROSIS OF CARDIOMYOCYTES AND PROGNOSIS IN PATIENTS WITH CHRONIC HEART FAILURE Abstract  PDF (Eng)  similar documents
E. N. Golovenko, D. A. Napalkov, V. A. Sulimov
"... and subendocardial perfusion damaging, which results in cardiomyocytes apoptosis and LV remodeling [1]. Results ..."
 
Vol 10, No 2 (2014) RESIDENT PROGENITOR CARDIAC CELLS IN PATIENTS WITH DILATED CARDIOMYOPATHY AND CONGESTIVE HEART FAILURE Abstract  similar documents
T. G. Kulikova, O. V. Stepanova, M. P. Valihov, A. Yu. Shhedrina, A. N. Samko, V. P. Masenko, S. N. Tereshhenko
"... Aim. To study content of resident progenitor cardiomyocytes in endomyocardial biopsy samples ..."
 
Vol 3, No 2 (2007) CORRECTION OF ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH CHRONIC COR PULMONALE BY ANGIOTENSIN II RECEPTORS ANTAGONISTS Abstract  similar documents
V. S. Zadionchenko, N. B. Holodkova, O. I. Nesterenko, I. V. Pogonchenkova, A. M. Shchikota, Y. V. Ignatova, I. Y. Malyshev, E. B. Manukhina, S. V. Kruglov, D. A. Pokidyshev, O. A. Zemnina
"... Aim. To evaluate intensity of endothelial dysfunction, processes of apoptosis, state of central ..."
 
Vol 6, No 3 (2010) ANTIHYPERTENSIVE AND ANTIOXIDATIVE EFFECTS OF CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT/OBESITY Abstract  similar documents
V. A. Nevzorova, E. S. Potapova, O. V. Nastradin
"... Aim. To evaluate an efficacy of the 24-week antihypertensive therapy based on the carvedilol ..."
 
Vol 4, No 3 (2008) ANGIOTENSIN II AND MYOCARDIAL INFARCTION Abstract  similar documents
O. P. Shevchenko, А. О. Shevchenko
"... . It contributes to inflammation of vessel intimae, oxidative stress, cells apoptosis, matrix remodeling, has pro ..."
 
Vol 12, No 5 (2016) Pathogenic Mechanisms of Atrial Fibrillation in Obesity Abstract  similar documents
O. M. Drapkina, M. V. Nikolaeva
"... fibrosis, cardiomyocyte overload by Na+ and Ca2+ ions, accumulation in the cells of unoxidized metabolic ..."
 
Vol 3, No 4 (2007) EFFECTS OF Β-ADRENOBLOCKERS ON MYOCARDIAL REMODELING, IMMUNO-INFLAMMATORY REACTIONS AND ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE AND CHRONIC HEART FAILURE Abstract  similar documents
A. N. Zakirova, N. E. Zakirova, I. M. Karamova, N. Kh. Khafizov, O. V. Rasskazova
"... . They were randomized in two groups. The first group was presented with 43 patients receiving carvedilol ..."
 
Vol 9, No 6 (2013) COMPARATIVE EFFICACY OF CHRONIC HEART FAILURE TREATMENT WITH PERINDOPRIL OR CARVEDILOL IN PATIENTS WITH ALCOHOLIC OR IDIOPATHIC DILATED CARDIOMYOPATHY Abstract  similar documents
I. V. Zhirov, G. K. Sarbalinova, S. N. Tereschenko
"... or beta-blocker carvedilol in patients with chronic heart failure (CHF) due to dilated cardiomyopathy ..."
 
Vol 11, No 1 (2015) MYOPATHY AS A SIDE EFFECT OF STATIN THERAPY: MECHANISMS OF DEVELOPMENT AND PROSPECTS FOR TREATMENT Abstract  similar documents
O. M. Drapkina, E. M. Chernova
"... of essential metabolites, destabilization of cell membranes, impaired expression of genes involved in apoptosis ..."
 
Vol 8, No 3 (2012) CARDIOTOXICITY ANTIPSYCHOTICS: MORPHO-ELECTROCARDIOGRAPHIC ASSOCIATIONS Abstract  similar documents
V. P. Volkov
"... .1% to 80.0±10.1% in groups 1 and 4, respectively), in specific volume of atrophied cardiomyocytes (from 8 ..."
 
Vol 7, No 4 (2011) USE OF ROSUVASTATIN AS A GEROPROTECTOR IN PEOPLE ENGAGED IN NATURAL GAS PRODUCING Abstract  similar documents
A. T. Abdrashitova, T. N. Panova, I. A. Belolapenko, M. V. Frenkel
"... cytokine - interleukin-8 and marker of apoptosis - protein p53 as well as aging rate slowdown. Conclusion ..."
 
Vol 4, No 2 (2008) BETA-ADRENOBLOCKERS AND PLATELET AGGREGATION. CARVEDILOL Abstract  similar documents
A. N. Zakirova, F. S. Zarudij, B. N. Garifullin
"... drug properties (water repellency, dipole moment, molecular mass). Trail results on carvedilol ..."
 
Vol 13, No 3 (2017) BETA-BLOCKERS AND RENOPROTECTION: THE POTENTIAL OF CARVEDILOL Abstract  similar documents
I. T. Murkamilov, I. S. Sabirov, V. V. Fomin, F. A. Yusupov
"... The review presented the importance of carvedilol using in terms of renoprotection in renal ..."
 
Vol 7, No 3 (2011) COMPARATIVE ANALYSIS OF ARTERIAL HYPERTENSION TREATMENT IN MEN AND WOMEN BASED ON THE RESULTS OF ACCORD STUDY (ACRIDILOLE IN COMBINATION THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AND OBESITY OR TYPE 2 DIABETES) Abstract  similar documents
S. A. Shalnova, S. Yu. Martsevich, A. D. Deev, Yu. V. Lukina, E. N. Hoseva
"... Aim. To compare the efficacy and safety of carvedilol in men and women with mild to moderate ..."
 
Vol 2, No 3 (2006) HEMODYNAMIC EFFECTS OF CARVEDILOL IN PATIENTS WITH ARTERIAL HYPERTENSION Abstract  similar documents
L. I. Markova, A. I. Radzevich
"... Aim. To evaluate the influence of carvedilol (Talliton, Egis, Hungary) on daily profile of blood ..."
 
Vol 5, No 1 (2009) DOPAMINE EFFECT ON CARDIAC REMODELING IN EXPERIMENT Abstract  similar documents
V. R. Veber, M. P. Rubanova, S. V. Zhmailova, P. M. Gubskaya, I. A. Suchenko, V. E. Goricina, T. M. Nurjanova
"... parameters of left and right ventricles were evaluated as well as density of cardiomyocytes, collagen ..."
 
Vol 5, No 4 (2009) METOPROLOL AND CARVEDILOL IN THERAPY OF ACUTE MYOCARDIAL INFARCTION: WHEN AND WHICH DRUG TO PREFER Abstract  similar documents
B. N. Garifullin, A. N. Zakirova, F. S. Zarudij
"... of metoprolol tartrate and carvedilol on MI pathogenesis are presented. Possible indications and treatment ..."
 
Vol 6, No 4 (2010) PHARMACOECONOMIC ANALYSIS OF CARVEDILOL THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC RISK FACTORS (ACCORDING TO THE CAMELLIA STUDY) Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko, A. D. Deev, S. A. Shalnova, R. G. Oganov
"... on emcarvedilol/em or metoprolol in patients with arterial hypertension (HT) 1-2 degrees and overweight/obesity ..."
 
Vol 5, No 3 (2009) COMPARATIVE CONTROLLED STUDY OF ANTIHYPERTENSIVE EFFICACY AND SAFETY OF CARVEDILOL IN PATIENTS WITH HYPERTENSION AND OBESITY OR DIABETES 2 TYPE (BASED ON RESULTS OF MULTICENTER TRIAL ACCORD) Abstract  similar documents
Yu. V. Yu.V. Lukina, S. Yu. Martsevich, A. D. Deev, S. A. Shalnova
"... Aim. To study efficacy and safety of beta-blocker with vasodilating properties emcarvedilol/em ..."
 
Vol 5, No 3 (2009) EFFECTS OF CARVEDILOL AND METOPROLOL ON VEGETATIVE REGULATION OF HEART AND MICROCIRCULATION IN PATIENTS WITH HYPERTENSION AND HIGH BODY MASS Abstract  similar documents
A. R. Kiselev, V. I. Gridnev, A. S. Karavaev, O. M. Posnenkova, V. A. Shvarts, V. I. Ponomarenko, M. D. Prokhorov, B. P. Bezruchko
"... Aim. To study effects of emcarvedilol/em and metoprolol on vegetative regulation of heart ..."
 
Vol 4, No 3 (2008) HEART FAILURE, DIABETES, BETA-BLOCKERS AND RISK OF HYPOGLYCEMIA Abstract  similar documents
A. A. Aleksandrov, O. А. Shatskaya, S. S. Kuharenko, E. N. Drozdova, I. Z. Bondarenko, N. D. Tabidze, M. V. Shestakova
"... Aim. To evaluate an influence of emcarvedilol/em on risk of hypoglycemia in patients with diabetes type ..."
 
Vol 4, No 5 (2008) CAMELLIA TRIAL: COMPARISON IN THERAPIES BASED ON CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT AND OBESITY Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko
"... for comparable study of efficacy and safety of therapies based on β-blockers (emcarvedilol/em and metoprolol ..."
 
Vol 6, No 2 (2010) EFFECTS OF CARVEDILOL ON PLATELET AGGREGATION IN MEN WITH ST-ELEVATION ACUTE MYOCARDIAL INFARCTION Abstract  PDF (Eng)  similar documents
A. N. Zakirova, B. N. Garifullin, F. S. Zarudij, N. E. Zakirova
"... Aim. To study influence of beta-blockers emcarvedilol/em and metoprolol tartrate on platelet ..."
 
Vol 13, No 3 (2017) EFFECT OF EPINEPHRINE ADMINISTRATION ON MYOCARDIAL REMODELING IN EXPERIMENTAL STUDY Abstract  similar documents
V. R. Veber, S. V. Zhmailova, M. P. Rubanova, P. M. Gubskaya
"... 0.05). The emcardiomyocytes/em density in both ventricles decreases considerably without reaching control ..."
 
Vol 8, No 4 (2012) COMPARISON OF THE INFLUENCE OF LONG-TERM TREATMENT BASED ON CARVEDILOL OR BISOPROLOL ON METABOLIC PARAMETERS IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY RESULTS OF THE RANDOMIZED OPEN-LABEL PARALLEL-GROUPS STEPPED TRIAL CABRIOLET (PART I) Abstract  similar documents
S. Y. Martsevich, S. N. Tolpygina
"... Aim. To compare antihypertensive and metabolic effects of long-term treatment with emcarvedilol/em ..."
 
Vol 6, No 4 (2010) HEART RATE VARIABILITY IN PATIENTS WITH PREVIOUS Q-WAVE MYOCARDIAL INFARCTION IN DIFFERENT TREATMENT SCHEMES IN EARLY POSTINFARCTION PERIOD Abstract  PDF (Eng)  similar documents
A. A. Abdullaev, R. M. Gafurova, U. A. Islamova, I. A. Kadieva, R. G. Khabchabov
"... ) received combined therapy with ramipril, emcarvedilol/em and trimetazidine. HRV parameters (derived from ECG 5 ..."
 
Vol 5, No 1 (2009) COMPARISON OF THERAPIES BASED ON CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY. THE FIRST RESULTS OF CAMELLIA TRIAL Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko, E. V. Shilova, A. D. Deev, S. A. Shalnova, R. G. Oganov, I. A. Velishanina, E. G. Volkova, Yu. E. Voskanjan, L. I. Gapon, P. Ya. Dovgalevskij, V. Ya. Ermolina, E. M. Idrisova, N. N. Ilov, A. R. Kiseleva, S Yu. Levashov, V. A. Nevsorova, G. I. Nechaeva, T. N. Panova, I. I. Reznik, V. V. Skibickij, L. A. Sokolova, V. P. Terentev, N. V. Hailo, A. V. Shabalin, T. V. Shnyukova, V. V. Yakusevich, E. N. Akulina, V. A. Budanova, T. S. Bondarenko, V. P. Voronina, I. N. Gozhaja, I. I. Igricenco, A. V. Drogan, N. A. Dmitrieva, F. M. Dyshekova, A. I. Zaiceva, A. N. Ikovnikova, G. A. Ilicheva, I. S. Irhina, L. A. Kovaleva, O. N. Kutkina, E. A. Kudrjashev, A. Z. Leonidova, E. N. Loginova, M. P. Marganjan, O. V. Nastradin, A. N. Nikitina, I. N. Nikolskaja, I. E. Pashinceva, A. S. Petrochenko, O. M. Pasnenkova, E. S. Potapova, A. A. Serazhim, M. N. Sergeev, V. V. Sidorenko, V. A. Simonov, D. V. Sirotenko, I. N. Spanderashvili, A. N. Strunina, E. S. Timoschenko, S. N. Tolpygina, M. R. Redkina
"... Aim. To evaluate antihypertensive and metabolic effects of the therapy based on emcarvedilol/em (C ..."
 
Vol 5, No 2 (2009) COMPARISON OF THE METABOLIC EFFECTS OF CARVEDILOL AND METОPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT AND OBESITY. THE CAMELLIA TRIAL Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko, E. V. Shilova, A. D. Deev, S. A. Shalnova, R. G. Oganov, I. A. Veliganina, E. G. Volkova, Yu. E. Voskanjan, L. I. Gapon, P Ya. Dovgalevskij, V. Ya. Ermolina, E. M. Idrisova, N. N. Ilov, A. R. Kiselev, S. Yu. Levashov, V. A. Nevzorova, G. I. Nechaeva, T. N. Panova, I. I. Reznik, V. V. Skibickij, L. A. Sokolova, V. P. Terentev, N. V. Hailo, A. V. Shabalin, T. V. Shnjukova, V. V. Yakusevich
"... Aim. To compare two therapies based on emcarvedilol/em or metoprolol in hypertensive patients ..."
 
Vol 4, No 2 (2008) COMPARISON OF CARVEDILOL AND BISOPROLOL EFFICACY IN PATIENTS WITH CHRONIC HEART FAILURE AND DIABETES TYPES 2 AFTER MYOCARDIAL INFARCTION Abstract  similar documents
M. E. Statsenko, S. V. Belenkova, O. E. Sporova, D. A. Ivanova, E. D. Evtereva
"... Aim. To compare efficacy of emcarvedilol/em and bisoprolol in patients with chronic heart failure (CHF ..."
 
Vol 9, No 6 (2013) DOES TREATMENT STRATEGY FOR ATRIAL FIBRILLATION INFLUENCE MYOCARDIAL CONTRACTILE FUNCTION? Abstract  PDF (Eng)  similar documents
V. I. Podzolkov, A. I. Tarzimanova, I. J. Loriya, L. N. Mokhammadi
"... - phy and emapoptosis/em of atrial emcardiomyocytes/em, ac- cumulation of fibroblasts and collagen induction [12 ..."
 
Vol 13, No 6 (2017) HEART RATE VARIABILITY, VENTRICULAR LATE POTENTIALS AND HEART RATE TURBULENCE AS INDICATORS OF CORONARY REPERFUSION IN ST SEGMENT ELEVATION MYOCARDIAL INFARCTION Abstract  similar documents
E. A. Shigotarova, E. V. Dushina, V. A. Galimskaya, V. E. Oleynikov
"... of the vessels of the microcirculatory bed, release of free radicals and alteration of emcardiomyocytes/em, especially ..."
 
Vol 1, No 3 (2005) CARDIORENAL RELATIONS AND QUALITY OF LIFE IN ELDERLY PATIENTS WITH CHRONIC HEART FAILURE IN LONG TERM THERAPY WITH CARVEDILOL AND BISOPROLOL Abstract  similar documents
M. A. Statsenko, I. A. Sporova, S. V. Belenkova, N. N. Shilina
"... . The average daily doses were 5,7+0,8 mg for and 32,6+3,4 mg for emcarvedilol/em. The duration of the observation ..."
 
Vol 4, No 3 (2008) ESTIMATION OF CLINICAL AND PHARMACOKINETIC EQUIVALENCE OF ORIGINAL AND GENERIC CARVEDILOLS IN PATIENTS WITH HYPERTENSION OF 1-2 GRADES Abstract  similar documents
E. I. Bambysheva, S. N. Tolpygina, D. F. Guranda, I. E. Koltunov, V. G. Belolipetskaja, S. J. Martsevich
"... ) and of generic (VedicardolR, ≪Synthesis≫, Russia) emcarvedilols/em with estimation of their serum level. And to study ..."
 
Vol 3, No 1 (2007) RATIONAL CHOICE OF Β-ADRENOBLOCKERS IN CHRONIC HEART FAILURE THERAPY Abstract  similar documents
M. L. Maximov
"... of metoprolol, bisoprolol and emcarvedilol/em had been proven in CHF therapy. Nebivolol was effective in elderly ..."
 
Vol 8, No 5 (2012) COMPARISON OF THE INFLUENCE OF LONG-TERM TREATMENT BASED ON CARVEDILOL OR BISOPROLOL ON METABOLIC PARAMETERS AND ERECTILE FUNCTION IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY RESULTS OF THE RANDOMIZED OPEN-LABEL PARALLEL-GROUPS STEPPED TRIAL CABRIOLET (PART 2) Abstract  similar documents
S. Y. Martsevich, S. N. Tolpigina
"... (EF) of long-term treatment with emcarvedilol/em or bisoprolol in patients with arterial hypertension (HT ..."
 
Vol 5, No 5 (2009) EFFICACY AND SAFETY OF VASOACTIVE BETA-BLOCKERS IN ACUTE PHARMACOLOGICAL TEST IN HYPERTENSIVE PATIENTS OF DIFFERENT AGES Abstract  similar documents
O. V. Fedorishina, A. A. Dzizinsky, K. V. Protasov, V. A. Protasova, T. I. Kucherova, E. G. Zakharova, D. D. Baskhaeva, T. S. Sukhoroslova, O. V. Perkova
"... Aim. To evaluate a short-term efficacy and safety of nebivolol and emcarvedilol/em in hypertensive ..."
 
Vol 5, No 6 (2009) RESULTS OF THE CAMELLIA TRAIL: IMPLEMENTATION IN A PRIMARY HEALTH CARE Abstract  similar documents
G. I. Nechaeva, E. N. Loginova
"... Aim. To compare the antihypertensive and metabolic effects of combined therapy (emcarvedilol/em ..."
 
Vol 5, No 6 (2009) ORGANOPROTECTIVE EFFECTS OF THE FIXED COMBINATION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITOR LISINOPRIL AND DIURETIC HYDROCHLOROTHIAZIDE Abstract  similar documents
E. A. Ryabikhin, M. E. Mozheiko
"... Aim. To compare the antihypertensive and metabolic effects of combined therapy (emcarvedilol/em ..."
 
Vol 10, No 6 (2014) ALCOHOLIC CARDIOMYOPATHY: BASIC ASPECTS OF EPIDEMIOLOGY, PATHOGENESIS AND PHARMACOTHERAPY Abstract  similar documents
A. O. Yusupova
"... развитием emапоптоза/em, хотя механизмы этих процессов до конца не изучены. К возможным механизмам поражения серд ..."
 
Vol 12, No 3 (2016) MEMBRANE BILE ACID RECEPTOR TGR5 - A NEW TARGET IN THE STUDY OF METABOLIC, INFLAMMATORY AND NEOPLASTIC DISEASES Abstract  PDF (Eng)  similar documents
O. M. Drapkina, E. I. Fomicheva
"... диабета и ожирения. Канцерогенез, emапоптоз/em и пролиферация Хорошо известно, что желчные кислоты принимают ..."
 
Vol 5, No 4 (2009) BISOPROLOL EFFICACY IN PATIENTS WITH ARTERIAL HYPERTENSION ASSOCIATED WITH CARDIOPULMONARY DISEASES Abstract  similar documents
G. N. Gorokchovskaya, M. M. Petina
"... дисфункции и смерти emкардиомиоцитов/em путем некроза и emапоптоза/em, уменьшением числа гипербинирующих emкардиомиоцитов/em ..."
 
Vol 8, No 2 (2012) ADDITIONAL USE OF TRIMETAZIDINE IN PATIENTS WITH CHRONIC HEART FAILURE. A META-ANALYSIS  similar documents
Lei Zhang, Yizhou Lu, Hong Jiang, Liming Zhang, Aijun Sun, Yunzeng Zou, Junbo Ge
"... повреждения, ингибирования воспаления и emапоптоза/em и улучшения функции эндоте- лия [5-7]. Поэтому ТМЗ считается ..."
 
Vol 13, No 2 (2017) POSSIBILITIES OF IVABRADINE, A SELECTIVE INHIBITOR OF ION F-CHANNELS OF SINUS NODE, IN PREVENTION OF ANTHRACYCLINE CARDIOTOXICITY IN PATIENTS WITH BREAST CANCER Abstract  similar documents
Yu. V. Vasyuk, V. V. Nesvetov, E. L. Shkolnik, L. D. Shkolnik, G. V. Varlan, G. E. Gendlin, E. I. Emelina
"... предполагает, что ге- нерация активных форм кислорода и перекисного окисления липидов emкардиомиоцитов/em приводит к ..."
 
Vol 3, No 5 (2007) EFFECTS OF BETA-BLOCKER METOPROLOL ON QUALITY OF LIFE IN ELDERLY PATIENTS WITH CHRONIC HEART FAILURE Abstract  similar documents
I. V. Vologdina
"... , защищают emкардиомиоциты/em от токсическо- го влияния катехоламинов, положительно влияют на ак- тивность ..."
 
Vol 8, No 5 (2012) OBSTRUCTIVE CORONARY ATHEROSCLEROSIS AND ISCHEMIC HEART DISEASE: AN ELUSIVE LINK!  similar documents
M. Marzilli, C.N.B. Merz, W. E. Boden, R. O. Bonow, P. G. Capozza, W. M. Chilian, A. N. DeMaria, G. Guarini, A. Huqi, D. Morrone, M. R. Patel, W. S. Weintraub
"... , разработать стратегии для защиты emкардиомиоцитов/em от ишемического повреждения, независимо от причинного ..."
 
Vol 9, No 1 (2013) FACTORS EFFECTING THE DECOMPENSATION OF CHRONIC HEART FAILURE IN THE ELDERLY Abstract  PDF (Eng)  similar documents
V. N. Larina, B. Ya. Bart, E. A. Vartanyan
"... metalloproteases, initiates molecular ways of signal transmission concerned with apopto- sis and emcardiomyocytes/em ..."
 
Vol 7, No 4 (2011) SARTANS OF THE SECOND GENERATION: THERAPEUTIC POTENTIAL EXTENSION Abstract  similar documents
S. V. Nedogoda
"... увеличивает число малых жировых клеток и переводят в состояние emапоптоза/em более крупные ади- поциты в подкожной ..."
 
Vol 6, No 5 (2010) WHY BETA-BLOCKERS ARE NOT PRESCRIBED TO PATIENTS WITH HEART FAILURE AND HOW TO IMPROVE IT? Abstract  similar documents
S. N. Tereshchenko, I. V. Zhirov
"... ) — emcarvedilol/em, group 3 (n=30) — nebivolol. Study duration was 6 months. Clinical examination (physical ..."
 
Vol 11, No 5 (2015) Insulin-like growth factor-1 and myocardial remodeling in female patients with arterial hypertension and metabolic syndrome Abstract  similar documents
A. N. Zakirova, E. R. Fatkullina, N. E. Zakirova, L. M. Zhamalov
"... усилению emапоптоза/em emкардиомиоцитов/em и про- грессированию процессов фиброзирования миокарда. Полученные ..."
 
Vol 2, No 1 (2006) SUPRAVENTRICULAR RHYTHM DISTURBANCES TREATMENT WITH ANTIARHYTHMIC DRUG III CLASS NIBENTAN IN PATIENTS WITH ISCHEMIC HEART DISEASE (EXPERIMENTAL, CLINICAL AND MORPHOLOGICAL EVIDENCES) Abstract  similar documents
I. A. Latfullin, R. F. Gaifullina
"... , хаотического расположения пучков emкардиомиоцитов/em, мышечно-эластической гиперплазии интимы сосудов, явлений ..."
 
Vol 2, No 4 (2006) “CYTOKINE” MODEL OF PATHOGENESIS OF CHRONIC HEART FAILURE AND THE OPPORTUNITIES OF NEW THERAPEUTIC STRATEGY IN DECOMPENSATED PATIENTS Abstract  similar documents
U. A. Vasuk, O. P. Dudarenko, E. N. Uschuk, E. L. Schkolnik, M. K. Serova
"... эндотелийзависимая дилатация артериол, уси- ливается процесс emапоптоза/em emкардиомиоцитов/em, избы- точного развития ..."
 
Vol 12, No 1 (2016) Effect of magnesium on the cardiovascular system in women Abstract  PDF (Eng)  similar documents
E. A. Ulubieva, A. G. Avtandilov
"... митохондриальных белков, элек- тролитный баланс митохондрий, открытие митохонд- риальной поры и emапоптоз/em. Дефицит ..."
 
Vol 4, No 4 (2008) BETA-ADRENOBLOCKERS IN XXI CENTURY: EPOCH END OR IMMORTALITY BEGINNING? A VIEW OF ORDINARY CARDIOLOGIST Abstract  similar documents
L. N. Malaj
"... – частота сердечных сокращений; КМЦ emкардиомиоциты/em, ЛЖ – левый желудочек, ГМЛЖ – гипертрофия миокарда ЛЖ ..."
 
Vol 7, No 6 (2011) INFLUENCE OF METOPROLOL SUCCINATE ON REGULATORY AND ADAPTIVE STATUS OF PATIENTS WITH CHRONIC HEART FAILURE FUNCTIONAL CLASS I. RESULTS OF NOT COMPARATIVE STUDY Abstract  similar documents
V. G. Tregubov, S. G. Kanorskiy, V. M. Pokrovskiy
"... проводилось. Между тем, доказано, что БАБ уменьшают некроз, emапоптоз/em и количество гиберинирующих кардиомио ..."
 
Vol 4, No 2 (2008) INHIBITOR OF SYNTHESIS OF TUMOR NECROSIS FACTOR-Α, PENTOXIFYLLINE, IN COMBINED THERAPY OF THE CHRONIC HEART FAILURE Abstract  similar documents
O. P. Dudarenko, E. L. Shkol’nik, , ,
"... артериол, усиливается emапоптоз/em emкардиомиоцитов/em, накапливается внеклеточный коллагеновый матрикс миокарда [2 ..."
 
Vol 3, No 2 (2007) OXIDATIVE STRESS AND POSSIBILITY TO CORRECT IT WITH ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN PATIENTS WITH MYOCARDIAL INFARCTION ASSOCIATED WITH DIABETES MELLITUS TYPE 2 Abstract  similar documents
K. S. Lexina, N. Y. Timofeeva, V. S. Zadionchenko, G. G. Shehian, K. A. Aldushina
"... сахарном диабете в emкардиомиоцитах/em (КМЦ) главенствующее положение занимают наруше- ния энергетического ..."
 
Vol 12, No 2 (2016) LEFT VENTRICULAR REMODELING IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION WITH AND WITHOUT ST SEGMENT ELEVATION Abstract  similar documents
N. E. Zakirova, Z. A. Kazieva, A. N. Zakirova
"... погибнуть вслед- ствие emапоптоза/em, так называемой «программируемой смерти» emкардиомиоцитов/em [6]. Представляется ..."
 
Vol 11, No 4 (2015) EFFECT OF «TREAT-TO-TARGET» ANTIRHEUMATIC THERAPY ON DIASTOLIC DYSFUNCTION OF THE LEFT AND RIGHT VENTRICLES IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS DURING 18 MONTHS OF OBSERVATION Abstract  similar documents
I. G. Kirillova, D. S. Novikova, T. V. Popkova, Yu. N. Gorbunova, E. I. Markelova, Yu. O. Korsakova, O. A. Fomicheva, A. V. Volkov, E. L. Luchikhina, N. V. Demidova, K. A. Kasumova, S. A. Vladimirov, M. A. Kanonirova, G. L. Lukina, A. A. Novikov, E. N. Aleksandrova, D. E. Karateev, E. L. Nasonov
"... ]. Иссле- дования на мышах показали, что ФНО-α может уси- ливать emапоптоз/em, гипертрофию, воспалительную реак ..."
 
Vol 10, No 5 (2014) THE ROLE OF IMMUNE INFLAMMATORY REACTIONS AND ENDOTHELIAL DYSFUNCTION IN MYOCARDIAL REMODELING AND PROGRESSION OF ISCHEMIC HEART DISEASE Abstract  similar documents
N. E. Zakirova, A. N. Zakirova
"... прямое повреж- дающее действие на мембраны emкардиомиоцитов/em (на- рушение Са2+-транспортирующей функции ..."
 
Vol 5, No 4 (2009) ANTIARRHYTMIC EFFICACY OF SOTALOL IN PATIENTS WITH TACHY-BRADY SYNDROME HAVING ATRIAL PACEMAKER WITH DIFFERENT ATRIAL ELECTRODE POSITION Abstract  similar documents
T. N. Novikova
"... патологии сердца является emапоптоз/em (естественная, запрограм- мированная, но более быстрая, чем в норме ..."
 
Vol 9, No 3 (2013) PROBLEMS AND PROSPECTS OF INTERMEDIARY METABOLISM CORRECTION IN PATIENTS WITH VASCULAR COMORBIDITY Abstract  similar documents
S. A. Rumyantseva, R. G. Oganov, V. A. Stupin, E. V. Silina, A. S. Orlova, S. B. Bolevich, V. V. Afanasev, E. N. Kabaeva, S. A. Volik
"... клеток и тканей при всех па- тологических процессах, вызванных тканевой ише- мией и ведущих к emапоптозу/em [3 ..."
 
Vol 10, No 3 (2014) NEW EMPHASES ON THE STUDY OF THE PATHOGENESIS OF CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION: FOCUS ON INFLAMMATORY MARKERS Abstract  similar documents
O. M. Drapkina, L. O. Palatkina
"... - гуляции синтеза и деградации фибриллярного колла- гена, изменение цитоскелета emкардиомиоцитов/em за счет ..."
 
Vol 9, No 2 (2013) INTERCHANGEABILITY OF MYOCARDIAL CYTOPROTECTORS IN PATIENTS WITH ISCHEMIC HEART DISEASE. DIFFICULT QUESTIONS –SIMPLE SOLUTIONS Abstract  similar documents
Zh. M. Sizova
"... процессов, оказывающих существенное влия- ния на emкардиомиоциты/em и миокард в целом. Это дикту- ет ..."
 
Vol 4, No 3 (2008) INFLUENCE OF COMBINED ANTIHYPERTENSIVE AND ANTIDEPRESSANT THERAPY ON LEFT VENTRICULAR REMODELING IN PATIENTS WITH ARTERIAL HYPERTENSION, ANXIETY AND DEPRESSION Abstract  similar documents
Y. A. Vasyuk, T. V. Dovzenko, E. A. Nesterova, I. A. Sadulaeva, K. V. Tarasova
"... является ком- пенсаторным процессом и обусловлена структурной адаптацией emкардиомиоцитов/em в ответ на ..."
 
Vol 6, No 3 (2010) ASSOCIATION OF CLINICAL AND GENETIC FACTORS WITH LEFT VENTRICLE HYPERTROPHY IN ARTERIAL HYPERTENSION Abstract  PDF (Eng)  similar documents
T. Yu. Kuznetsova, D. V. Gavrilov, L. M. Samohodskaya, D. V. Rebrikov, S. A. Morozova, P. I. Makarevich, A. V. Kolotvin, A. B. Balatsky, A. Yu. Postnov, S. A. Boitsov
"... activation and output of factors stimulating emcardiomyocytes/em growth. Obesity is an impetus for LVH development ..."
 
Vol 9, No 5 (2013) ROLE OF THE METABOLITE THERAPY FOR THE TREATMENT OF CHRONIC HEART FAILURE Abstract  similar documents
L. N. Maksimova, M. L. Maksimov, Y. R. Nartsissov, R. M. Zaslavskaya, E. V. Kalinina
"... emкардиомиоцитов/em, улучшалось восстановление сократительной способности миокарда во время ре- перфузии. Потребление ..."
 
Vol 11, No 4 (2015) PROSPECTS FOR CYTOPROTECTORS USE IN THE ELDERLY PATIENTS THROUGH THE EXAMPLE OF CALCIFIED AORTIC STENOSIS AND ISCHEMIC HEART DISEASE Abstract  similar documents
N. Yu. Karpova, M. A. Rashid, N. A. Shostak, I. V. Pogonchenkova, T. V. Kazakova
"... внезапным повышением проницаемости их мем- бран, некрозом и/или emапоптозом/em emкардиомиоцитов/em [31] • Нарушение ..."
 
Vol 10, No 1 (2014) THE EFFICACY OF MELDONIUM IN REDUCTION OF CARDIAC ELECTRICAL INSTABILITY IN PATIENTS WITH ISCHEMIC STROKE Abstract  similar documents
A. A. Abdullaev, A. D. Magomedov, U. A. Islamova, Z. R. Umahanova
"... окисления липидов, что вызывает гибель нейронов вследствие emапоптоза/em и некроза. При инсульте сердце и мозг ..."
 
Vol 11, No 2 (2015) LOW SODIUM DIET: PROS AND CONS Abstract  similar documents
O. M. Drapkina, R. N. Shepel'
"... , секретируемых emкардиомиоцитами/em предсердий и желудочков. Мозго- вой натрийуретический пептид (МНП) секретируется ..."
 
Vol 13, No 4 (2017) PATIENT WITH CHRONIC HEART FAILURE. RATIONAL CHOICE OF THERAPY Abstract  similar documents
O. M. Drapkina, D. U. Akasheva
"... чувствительности ба- рорецепторов, экскрецией электролитов (K+, Mg2+) и emапоптозом/em emкардиомиоцитов/em. Таким образом ..."
 
Vol 8, No 5 (2012) TITERS OF ANTIBODIES TO Β1-ADRENOCEPTOR AND M2 CHOLINERGIC RECEPTORS IN PATIENTS WITH VENTRICULAR ARRHYTHMIAS WITHOUT AN ORGANIC CARDIOVASCULAR DISEASE AND THEIR POSSIBLE CLINICAL SIGNIFICANCE Abstract  similar documents
M. M. Rogova, N. A. Mironova, E. S. Rodionova, T. A. Malkina, K. A. Zykov, Zh. D. Bespalova, R. Sh. Bibilashvili, E. E. Efremov, S. P. Golitsyn
"... инфекционном поражении сердца (острый миокардит), при которых про- исходит emапоптоз/em и/или некроз emкардиомиоцитов/em ..."
 
Vol 12, No 2 (2016) ESTIMATION OF HIGHLY SENSITIVE TROPONIN TESTS IN THE DIAGNOSIS OF ACUTE CORONARY SYNDROME Abstract  similar documents
L. V. Kremneva, S. N. Suplotov, S. V. Shalaev
"... миокарда; • emапоптоз/em emкардиомиоцитов/em (связан с активацией ка- спаз, вызывающих деградацию структурных ..."
 
Vol 9, No 6 (2013) СARDIOPROTECTION IN PATIENTS WITH HYPERTENSION – THE ROLE OF LOSARTAN Abstract  similar documents
I. I. Chukaeva, Ya. G. Spiryakina
"... АД, т.е. прямым антипролиферативным действием на emкардиомиоциты/em и фибробласты миокарда. Механизм ..."
 
Vol 4, No 5 (2008) MOLECULAR MECHANISMS OF ACTION OF MAGNESIUM OROTATE ON CARDIOVASCULAR SYSTEM Abstract  similar documents
I. Yu. Torshin, O. A. Gromova
"... -зависимых рецепторов, ко- торые вовлечены в вазореактивные реакции, emапоптоз/em и секрецию цитокинов. Подобно ..."
 
Vol 9, No 5 (2013) THE ROLE OF PARVOVIRUS B19 IN THE DEVELOPMENT OF INFLAMMATORY CARDIOMYOPATHY Abstract  similar documents
A. Yu. Shchedrina, A. A. Skvortsov, K. A. Zykov, A. A. Safiullina, S. N. Tereshchenko
"... emкардиомиоцитах/em взрос- лого человека [37]. Р-антиген необходим для связы- вания, но недостаточен для проникновения ..."
 
Vol 8, No 4 (2012) UP TO DAY POSSIBILITIES OF ATRIAL FIBRILLATION PREVENTION Abstract  similar documents
E. A. Protasova, N. V. Furman, O. V. Reshet'ko
"... ), усиливается кол- лагенообразование, приводящее к развитию фиброза и emапоптоза/em emкардиомиоцитов/em [39]. Основываясь ..."
 
Vol 10, No 3 (2014) ATRIAL FIBRILLATION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE Abstract  similar documents
E. I. Leonova, G. G. Shehan, V. S. Zadionchenko, K. M. Bogatyrova
"... супероксид анион, индуцирую- щий emапоптоз/em. Таким образом, происходит повреж- дение билипидного слоя ..."
 
Vol 11, No 5 (2015) Features of the in-hospital course of myocardial infarction in patients with glucose metabolism disorders Abstract  similar documents
B. U. Mardanov, M. N. Mamedov, M. N. Korneeva, R. G. Oganov
"... утверждают, что увеличение внутриклеточной кон- центрации липидов в emкардиомиоцитах/em и гипер- экспресия ..."
 
Vol 6, No 1 (2010) AMLODIPINE IN TREATMENT OF PATIENTS WITH CORONARY ARTERY DISEASE: FOCUS ON ANTIATHEROSCLEROTIC PROPERTIES Abstract  similar documents
Yu. M. Lopatin
"... emкардиомиоцитами/em. Это определяет снижение об- щего периферического сосудистого сопротивления и от- сутствие влияния ..."
 
Vol 6, No 6 (2010) THE CHOICE OF DRUG FROM THE STANDPOINT OF EVIDENCE-BASED MEDICINE: CASE STUDY OF BETA-BLOCKERS Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko, Yu. V. Lukina
"... (исследования US emCArvedilol/em, MERIT-HF, CIBIS- II)[12-14]. Назначение небиволола пожилым больным с сердечной ..."
 
Vol 3, No 5 (2007) THE EFFECT OF ENALAPRIL ON THE FUNCTIONAL AND APOPTOTIC ACTIVITY OF NEUTROPHILS IN PATIENTS WITH RHEUMATIC HEART DISEASE Abstract  similar documents
M. V. Ilyin, A. O. Khrustalev
"... нейтрофилов [8]. emАпоптоз/em привлекает к себе внимание исследовате- лей как потенциальный патогенетический ..."
 
Vol 9, No 3 (2013) EVALUATION OF RANOLAZINE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND CHRONIC STABLE ANGINA. RESULTS FROM THE TERISA RANDOMIZED CLINICAL TRIAL (TYPE 2 DIABETES EVALUATION OF RANOLAZINE IN SUBJECTS WITH CHRONIC STABLE ANGINA) Abstract  similar documents
, , , , , , , , , , ,
"... механизмы еще предстоит определить. Существуют, однако, доказа- тельства того, что в emкардиомиоцитах/em, которые ..."
 
Vol 8, No 4 (2012) HIGH SELECTIVE LONG-ACTING Β1-BLOCKER WITH A VASODILATING EFFECT NEBIVOLOL IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE Abstract  similar documents
V. P. Lupanov
"... , в том числе, на мем- бранах emкардиомиоцитов/em. Синдром отмены клини- чески проявляется тахикардией ..."
 
Vol 12, No 5 (2016) Features of the Hemostasis and Platelets Enzyme Activity in Patients with Different Sensitivity to Acetylsalicylic Acid by the Acute Coronary Syndrome Abstract  similar documents
I. Yu. Grinshtein, A. A. Savchenko, Yu. I. Grinshtein, M. M. Petrova
"... platelet emapoptosis/em. Int J Mol Sci 2015; 16 (5): 11087-100. 16. Korla K., Vadlakonda L., Mitra C.K. Kinetic ..."
 
Vol 10, No 2 (2014) KEY PATHOGENETIC ASPECTS AND CLINICAL RELEVANCE OF MECHANICAL DYSSYNCHRONY Abstract  similar documents
Yu. V. Stavtseva, S. V. Villevalde, A. V. Sveshnikov, J. D. Kobalava
"... отделах сердца со- провождается emапоптозом/em, ишемией и замещением предсердных emкардиомиоцитов/em соединительной ..."
 
Vol 12, No 2 (2016) PLEIOTROPIC EFFECTS OF VITAMIN D Abstract  similar documents
O. M. Drapkina, R. N. Shepel
"... [10]. Витамин D оказывает влияние на синтез и секрецию emкардиомиоцитами/em предсердного ..."
 
Vol 12, No 4 (2016) Organoprotective effects of serelaxin in patients with severe decompensated heart failure Abstract  similar documents
Z. D. Kobalava, S. V. Villevalde, A. E. Solov'jova, I. A. Merai
"... , окислительного стресса, emапоптоза/em, фиброза и стимуляции ангиогенеза [2,3]. В клиническом исследовании III фазы ..."
 
Vol 13, No 3 (2017) ANGIOTENSIN RECEPTOR BLOCKERS WITH PLEIOTROPIC PROPERTIES: A NEW STANDARD IN CARDIOVASCULAR RISK MANAGEMENT AND TREATMENT OF HYPERTENSION Abstract  similar documents
V. I. Podzolkov, M. V. Pisarev
"... cardiomyocytes Рост миоцитов сосудов и emкардиомиоцитов/em ↑ Endothelin secretion Секреция эндотелина ↑ Collagen ..."
 
Vol 5, No 5 (2009) EFFECT OF MITRAL REGURGITATION ON CHRONIC HEART FAILURE COURSE AND STRUCTURE-FUNCTIONAL HEART STATE Abstract  PDF (Eng)  similar documents
V. N. Larina, B. Y. Bart, M. P. Mikhaylusova, B. N. Mamtsev
"... растяжимости emкардиомиоцитов/em спо- собствует удлинению саркомеров, которые являются ключевыми ..."
 
Vol 5, No 2 (2009) INNOVATIVE ANTIHYPERTENSIVE THERAPY IN THE LIGHT OF COMPLETED CLINICAL TRIALS Abstract  similar documents
N. A. Nikolaev
"... и активности отвечающего за синтез оксида азота фер- мента eNOS, замедление скорости emапоптоза/em ..."
 
Vol 5, No 1 (2009) NEW DEFINITIONS OF MYOCARDIAL INFARCTIONS (COMMENTS ON “UNIVERSAL DEFINITIONS OF MYOCARDIAL INFARCTION” PUBLISHED IN №5, 2008) Abstract  similar documents
A. V. Shpector, E. Yu. Vasilyeva
"... , понимается гибель emкардиомиоцитов/em вследствие ишемии. Наиболее па- тогномоничным признаком того, что в миокарде ..."
 
Vol 8, No 2 (2012) CURRENT TARGET OF ANTIHYPERTENSIVE THERAPY. DATA FROM CLINICAL TRIALS. PART 2 Abstract  similar documents
V. V. Popov, N. A. Bulanov, G. G. Ivanov
"... . Protective effects of BAY 41–2272 (sGC stimulator) on hyper- tension, heart, and emcardiomyocyte/em hypertrophy ..."
 
Vol 10, No 5 (2014) DIABETIC CARDIOMYOPATHY. RESISTIN: A CONTROL OF A MYOCARDIAL HYPERTROPHY Abstract  similar documents
An. A. Aleksandrov, O. A. Shatskaya, S. S. Kuharenko, M. N. Yadrihinskaya, E. N. Abdalkina, E. N. Drozdova, M. V. Shestakova
"... ]. У человека резистин вырабатывается клетками жи- ровой ткани, макрофагами, emкардиомиоцитами/em, клет ..."
 
Vol 6, No 2 (2010) NEBIVOLOL – ESPECIAL BETA-ADRENOBLOCKER Abstract  similar documents
T. Műnzel, T. Gori
"... , Mehlhorn U, Schwinger RH. Nebivolol, bucindolol, metoprolol and emcarvedilol/em are devoid of intrinsic ..."
 
Vol 4, No 3 (2008) COMBINED ANTIHYPERTENSIVE THERAPY IN METABOLIC SYNDROME Abstract  similar documents
E. I. Mananko, E. A. Bushkova, E. M. Idrisova, A. I. Vengerovsky
"... influence of emcarvedilol/em on risk of hypoglycemia in patients with diabetes type 2 (D2) and chronic heart ..."
 
Vol 3, No 1 (2007) SECONDARY MITOCHONDRIAL DYSFUNCTION IN ACUTE CORONARY SYNDROME Abstract  similar documents
Y. A. Vasyuk, K. G. Kulikov, O. N. Kudryakov, O. V. Krikunova, I. A. Sadulaeva
"... прежде всего отражается на метаболизме в emкардиомиоцитах/em в виде нарушения функционирования ..."
 
Vol 11, No 2 (2015) A SELECTIVE ANTAGONIST OF MINERALOCORTICOID RECEPTOR EPLERENONE IN CARDIOLOGY PRACTICE Abstract  similar documents
B. B. Gegenava, O. M. Drapkina
"... COMET (emCarvedilol/em Or Metoprolol European Trial) [38] и SHIFT (Systolic Heart failure treatment with the ..."
 
Vol 8, No 3 (2012) STATINS AND MYOPATHY: MOLECULAR MECHANISMS Abstract  similar documents
O. M. Drapkina, E. M. Chernova, O. N. Korneeva
"... митохондриальную дисфункцию, не- стабильность мембран, нарушают экспрессию генов, от- вечающих за emапоптоз/em ..."
 
Vol 6, No 2 (2010) CLINICAL APPROACHES TO INTERPRETATION OF CLINICAL TRAILS RESULTS ON BETA-BLOCKERS FOR THE TREATMENT OF PATIENTS WITH CHRONIC HEART FAILURE Abstract  similar documents
S. R. Giljarevskiy, I. M. Kuzmina
"... Congestive Heart Failure, CIBIS II — Cardiac Insufficiency Bisoprolol Study и COPERNICUS — emCarvedilol/em ..."
 
1 - 100 of 235 Items 1 2 3 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)